Angiotensin-Converting Enzyme (ACE) Inhibition

[1]  J. Östman.  β-adrenergic blockade and diabetes mellitus. A review , 2009 .

[2]  I. Brajkovich,et al.  Effect of acute hyperglycaemia on plasma potassium and aldosterone levels in Type 2 (non-insulin-dependent) diabetes , 1982, Diabetologia.

[3]  E. Friedman,et al.  Diabetic Renal-Retinal Syndrome , 1998, Springer Netherlands.

[4]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[5]  R. Heel,et al.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. , 1986, Drugs.

[6]  S. Giannini,et al.  Captopril in the treatment of hypertension in type I and type II diabetic patients. , 1985, Postgraduate medical journal.

[7]  S. Draibe,et al.  Inadequate aldosterone response to hyperkalemia during angiotensin converting enzyme inhibition in chronic renal failure , 1985, Clinical pharmacology and therapeutics.

[8]  P. Weidmann,et al.  Pressor Factors and Responsiveness in Hypertension Accompanying Diabetes Mellitus , 1985, Hypertension.

[9]  C. Mogensen,et al.  Effect of Antihypertensive Treatment on Progression of Incipient Diabetic Nephropathy , 1985, Hypertension.

[10]  R. Barbera,et al.  [Treatment of hypertension in the diabetic with captopril]. , 1985, Minerva medica.

[11]  C. Christensen.  Rapidly Reversible Albumin and β2‐microglobulin Hyperexcretion in Recent Severe Essential Hypertension , 1983, Journal of hypertension.

[12]  C. Dollery,et al.  GLUCOSE INTOLERANCE IN HYPERTENSIVE PATIENTS TREATED WITH DIURETICS; A FOURTEEN-YEAR FOLLOW-UP , 1982, The Lancet.

[13]  J. Staessen,et al.  Captopril in the treatment of hypertension. , 1982, Acta clinica Belgica.

[14]  R. Tarazi,et al.  Long‐Term Converting Enzyme Inhibition and Sympathetic Nerve Function in Hypertensive Humans , 1981, Hypertension.

[15]  J. Biollaz,et al.  ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421". , 1981, The Lancet.

[16]  R. Maciel,et al.  Radioimunoensaio da atividade de renina plasmatica : aspectos metodologicos , 1981 .

[17]  R. Krohn,et al.  Preparation and Use of a Boronic Acid Affinity Support for Separation and Quantitation of Glycosylated Hemoglobins , 1981 .

[18]  R. DeFronzo,et al.  Effect of graded doses of insulin on splanchnic and peripheral potassium metabolism in man. , 1980, The American journal of physiology.

[19]  J. Laragh,et al.  Interruption of the Renin‐Angiotensin System in Hypertensive Patients by Captopril Induces Sustained Reduction in Aldosterone Secretion, Potassium Retention and Natriuresis , 1979, Hypertension.

[20]  J. Langan,et al.  A simple radioimmunoassay for urinary aldosterone. , 1974, The Journal of clinical endocrinology and metabolism.

[21]  A. R. Christlieb,et al.  Diabetes and hypertensive vascular disease. Mechanisms and treatment. , 1973, The American journal of cardiology.